Arkolith/Insider Trading/IKNA/Form 4

Stampacchia Otello

DirectorIkena Oncology, Inc. (IKNA) · full profile →Form 4 · filed Apr 1, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 30, 2021Conversion(C)1.8M——1.8M
Mar 30, 2021Grant(A)450K$16.00$7.2M2.2M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 30, 2021Conversion(C)12.9M——0
Dec 21, 2020Grant(A)12.9M$1.40$18.0M12.9M

Transaction Codes

C
Conversion of a derivative
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-21-014390) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML